
If you’ve been following the latest developments in weight management, you’ve probably heard about GLP-1 weight loss injections.
Medications such as semaglutide and tirzepatide have changed the conversation around obesity treatment. But social media often makes these medications sound like a simple shortcut to weight loss.
The reality is more nuanced.
GLP-1-based medicines can be highly effective for appropriately selected patients, but they are prescription medicines, they have potential side effects and contraindications, and they should be used as part of a comprehensive weight-management plan.
The World Health Organization’s 2025 guidance recognizes GLP-1 therapies as one option for long-term treatment of obesity in adults, while emphasizing healthy eating, physical activity and professional support as part of comprehensive care.
At Kayakalpa Clinic in Vadodara, the decision to use medication begins with understanding the individual’s health, metabolic risk, weight history and treatment goals.
GLP-1 stands for glucagon-like peptide-1, a hormone involved in appetite regulation and blood glucose control.
GLP-1 receptor agonists mimic some of the effects of this naturally occurring hormone.
They can:
Tirzepatide is slightly different. It acts on both GIP and GLP-1 pathways, which is why it is often described as a dual GIP/GLP-1 receptor agonist.
Two names frequently discussed in medical weight management are semaglutide and tirzepatide.
Semaglutide is a GLP-1 receptor agonist used in specific formulations for diabetes and chronic weight management.
Tirzepatide activates both GIP and GLP-1 receptors.
For example, the U.S. FDA approved tirzepatide under the brand Zepbound for chronic weight management in adults with obesity, or adults with overweight plus at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity.
Important: Brand names, approvals, prescribing criteria and availability can vary by country. A medication should only be prescribed based on the patient’s individual medical circumstances and the applicable local regulatory guidance.
One reason these medicines can be effective is that they influence the biological systems involved in hunger and satiety.
Instead of simply telling someone to “eat less,” treatment can help some patients experience:
Less hunger → better appetite control → lower food intake → gradual weight loss
This can be particularly relevant for people who have struggled with persistent hunger, food cravings or repeated weight regain despite sustained lifestyle efforts.
However, response varies considerably between individuals.
No.
This is one of the most important messages patients should understand.
A high body weight alone does not automatically mean someone should receive a GLP-1 medication.
Prescription weight-management medicines are generally considered for people with overweight or obesity when lifestyle interventions alone have not produced sufficient improvement and when the potential benefits outweigh the risks. Specific eligibility criteria depend on the medication and local prescribing guidance.
A doctor may consider:
This is perhaps the biggest misconception surrounding weight-loss injections.
Medication does not replace healthy eating, physical activity, sleep or behavioral change.
Evidence-based guidance recommends combining weight-management medication with lifestyle interventions.
At Kayakalpa, the objective isn’t simply:
“Take an injection and lose weight.”
Instead, the approach is:
Medical assessment + appropriate treatment + nutrition + movement + behavior + monitoring
That is what makes medical weight management different from a quick-fix weight-loss program.
Another important question is whether weight stays off after stopping treatment.
Weight regain can occur after discontinuing weight-management medication. NIDDK notes that people may regain some weight after stopping treatment, which is one reason long-term weight management needs to include sustainable eating and physical-activity habits.
This doesn’t mean the medication has “failed.”
Rather, it highlights an important principle:
The appropriate duration of treatment should be discussed with a physician based on response, benefits, side effects and individual circumstances.
GLP-1-based medicines commonly cause gastrointestinal symptoms.
These may include:
WHO notes that gastrointestinal side effects are common and that more serious gastrointestinal and other complications have also been associated with these therapies and continue to be evaluated.
This is why taking these medicines without medical supervision is not advisable.
Your doctor needs to consider your medical history, other medications, dose escalation and any symptoms that develop during treatment.
The growing popularity of GLP-1 medicines has also increased demand for products obtained outside appropriate medical and pharmacy channels.
This creates several concerns:
WHO has specifically warned about the spread of falsified and substandard GLP-1 products and emphasizes regulated distribution and prescribing by qualified healthcare professionals.
A weight-loss injection is still a prescription medicine — not a cosmetic product.
At a physician-led weight-management clinic, treatment should begin with assessment rather than immediately starting medication.
At Kayakalpa Clinic, Vadodara, evaluation may include:
Understanding your weight trajectory, previous diets, medications and existing conditions.
Depending on your clinical situation, this may include blood glucose, HbA1c, lipids and other relevant investigations.
Understanding body fat, muscle mass and other body-composition parameters can provide more information than body weight alone.
Nutrition, physical activity, sleep, stress and eating patterns all matter.
Based on your individual profile, your doctor can discuss lifestyle interventions and, when clinically appropriate, medication options.
Weight management is closely connected with metabolic health.
For people with obesity or overweight and related health conditions, meaningful weight loss may help improve several cardiometabolic risk factors.
For example, weight reduction can support improvements in:
The specific benefits depend on the individual and the treatment used.
At Kayakalpa Clinic, the focus is not on prescribing the newest medication to everyone.
The question is:
For some patients, lifestyle intervention may be sufficient.
For others, medication may be appropriate.
Some may need evaluation for thyroid disease, insulin resistance, PCOS, diabetes, sleep problems or other contributors to weight gain.
This is why medical weight management should be individualized.
Consider speaking with a doctor if you:
If you’re searching for:
GLP-1 weight loss injections in Vadodara
Medical weight loss in Vadodara
Weight loss doctor in Vadodara
Obesity treatment in Vadodara
Weight loss clinic in Vadodara
Metabolic physician in Vadodara
Kayakalpa Clinic provides physician-led weight-management care focused on Precision Medicine, Lifestyle Medicine and Metabolic Health.
The goal is not rapid weight loss at any cost.
They can be appropriate for selected patients when prescribed and monitored by a qualified healthcare professional. They are not suitable for everyone and can cause side effects.
No. Obesity is a chronic condition, and long-term management may be required. Weight can return after medication is stopped.
Medication should not be considered a substitute for healthy eating and physical activity. Comprehensive lifestyle intervention remains an important part of treatment.
Some GLP-1-based medicines are used in diabetes management, while certain formulations are approved for chronic weight management. The appropriate medication depends on the patient’s diagnosis and clinical situation.
No. A doctor should assess whether the medication is appropriate based on medical history, weight-related health risks, other medications and potential contraindications.